Lance Barrow was promoted to coordinating producer and lead game producer for THE NFL ON CBS in May 2004. Since the NFL returned to the CBS Television Network in 1998, Barrow had served as the producer for the Network's NFL announce team of Dick Enberg and Dan Dierdorf for six seasons and served as replay director for CBS Sports' coverage of Super Bowl XXXV and Super Bowl XXXVIII.

An eight-time Emmy Award-winner, Barrow joined CBS Sports in May 1975 as a spotter/researcher for the Network's golf coverage. He has served in virtually every capacity of CBS Sports' golf production. Barrow assumed the position of coordinating producer, CBS Sports golf, in January 1997 and has produced the majority of the Network's golf coverage since 1996, including the Network's historic coverage of the Masters® and PGA Championship.

Barrow produced CBS Sports' coverage of ski jumping and nordic combined at the 1994 Olympic Winter Games and was the associate director of the primetime broadcasts at the 1992 Olympic Winter Games. He also has served as the producer for coverage of NCAA basketball, college football and auto racing. Barrow produced coverage of the 1998 Daytona 500, for which he received an Emmy nomination. As an associate producer, his credits include the Masters and PGA Championship; NCAA men's Final Four; Daytona 500; the U.S. Open Tennis Championships; THE NFL TODAY and six Super Bowls. He has earned Emmy Awards for his work on the NCAA Men's Basketball Championship, the Daytona 500 and the NFL.

Barrow attended to Abilene Christian University in Texas, where he played football and baseball. He earned a communications degree in 1978.

Michael is the Founder and Managing Member of R-Squared. With the assistance of a Chief Technology Officer and a team of coders/developers, Michael consultatively designs affordable and effective technological solutions for operational and compliance improvement. He is a nationally recognized compliance expert who frequently consults, publishes and presents on topics of healthcare corporate compliance, privacy, and third party coverage and reimbursement. Michael serves on manufacturer, health system, and health plan compliance committees, and on several Advisory Boards, including those for BNA’s Medical Device and Law Report, Matthew Bender/Lexis Nexis Healthcare, AIS Report on Patient Privacy, and Seton Hall University School of Law’s Corporate Compliance Officer Certification Program. Michael is the chief designer of R-Squared’s Arrangements KeeperSM, a compliance and contract management tool designed specifically to evidence compliance with requirements related to manufacturer/physician relationships, and SpendTrackerSM, a highly scalable and interoperable program that automates tracking and reporting of physician marketing/gift expenditures.

Michael is a former Partner within the Washington, DC health law practice of a national law firm. He received his B.A. in economics from Wake Forest University, and his J.D. from Seton Hall University School of Law, with a concentration in health law from the Health Law and Policy Program.

Guy Cook is President, CEO, and CSO of the Company. Mr. Cook is considered an international expert in biofilm science and its application. He is published in the biofilm field and has been invited to speak at many prominent biofilm conferences, including the "Anti-Infective Materials Seminar” in Tokyo and the FDA-CDRH Antimicrobial Device Efficacy Testing Seminar.

Prior to founding Bacterin in 1997, Mr. Cook started his career as a product specialist in the Image Analysis Department for Laboratory Equipment Company in Chicago. He later became President of Delta Resources in Crystal Lake, Illinois, which specialized in developing customized image analysis solutions for the academic community. In 1996 he moved to Montana and worked as a confocal microscopist for the Center for Biofilm Engineering at the Montana State University where he developed several proprietary testing models for the medical device industry. Mr. Cook attended Indiana University and received Bachelor of Science degrees in finance and economics.

Dr. Craig's clinical focus is on arthroscopy, sports medicine, rotator cuff injury, and shoulder replacement surgery. An internationallyrenowned shoulder surgeon who lectures throughout the United States and abroad, he has been the designer of a total shoulder replacement system and a pioneer in rotator cuff repair technology.

Educated at Princeton University and Columbia College of Physicians and Surgeons, Dr. Craig spent his early professional career at the University of Minnesota before joining Hospital for Special Surgery as an attending surgeon. He is also a professor of clinical orthopedic surgery at Weill Cornell Medical College.

In addition to his practice of Orthopedic Surgery, he has recently completed a master’s degree in public health at Columbia University, has written and lectured on many aspects of health care, and is a health columnist for MSNBC.com. Dr. Craig has a web site at www.dredwardcraig.com.

Joe has been with Oberg since 1982. He has held various positions including his current as the Director of Technical Development and previously as Manager of Prototypes, Head of Engineering for Plastic Injection Molding and Precision Tool & Die Maker. Before joining Oberg, Joe worked in Quality Control at Gould Brown Boveri.

He attended University of Pittsburg and studied Mechanical Engineering in addition to studying electrical and chemical engineering at Drexel University.

Nick Deeter brings more than 29 years of business leadership and health care industry experience to his role as OrthoPediatrics’ Chairman of the Board, President and Chief Executive Officer. As the company’s founder and visionary, he is responsible for setting the strategic direction and long-term growth plans for OrthoPediatrics. In this capacity, he leverages his successful track record of developing and commercializing medical innovations, orthopedic devices and implants for the global health care market.

Mr. Deeter’s distinguished orthopedic and medical device career began at Zimmer, Inc. and includes more than two decades of executive leadership positions for other well-respected medical organizations. Prior to forming OrthoPediatrics, he spent seven years with DePuy Orthopaedics, a Johnson & Johnson company where he was responsible for health care compliance administration, medical affairs and orthogenesis. This included managing surgeon relationships, product engineering, production and marketing of custom implants and limb preservation products. Mr. Deeter also served as founder, Chairman, President and CEO of ViAtro, Corp., a medical device company specializing in infection control products; Vice President of University Technology Inc. at Case Western Reserve University, managing the technology transfer process of more than $100 million dollars per year of medical research; and President of Medical Ventures Ltd., a venture capital firm that initially funded STERIS Corp. Additionally, he managed the orthopedic and respiratory products at Invacare Corporation, the world leader in durable medical equipment.

Mr. Deeter earned an MBA from Case Western University and a Bachelor’s Degree in Engineering from Purdue University. He currently serves on the Boards of Trustees of the Biomedical Engineering Department at Case Western Reserve University, as well as AdvaMed, the medical device industry’s largest lobbying group.

Raj Denhoy is a Director in the Research Department at Thomas Weisel Partners LLC, where he covers Medical Device companies. He joined the firm in 2008 and is based in New York. Raj has followed the device industry for 9 years and previously was a Senior Research Analyst at Bear Stearns and Piper Jaffray. He has also worked in research at JP Morgan and Banc of America Securities. Raj received a Masters in Business Administration from Cornell University, a Masters of Science in Human Physiology from Georgetown University and a Bachelor’s degree in Biology from the University of California, Berkeley.

John Devine holds the position of Senior Product Development Manager with Invibio Biomaterial Solutions. This role involves developing and creating new materials for specific application needs in areas such as spine and general orthopaedics in addition to generating application specific data to accelerate pace and acceptance of new materials in conservative medical implant areas.

Operating closely at the material/device interface, Dr. Devine provides insight into the demands and challenges in introducing new biomaterials within the implantable devices market, in addition to a broad knowledge of current biomaterial offerings and challenges. Dr. Devine is a named inventor on a number of patented inventions and has contributed to presentations at shows such as Spinal Arthroplasty Society, British Orthopaedic Society and Society for Biomaterials in addition to authoring peer reviewed articles.

Working with Invibio, Dr. Devine has helped introduce a range of advanced biomaterials to the market and has a current interest in the potential of these materials as bearing components in spinal arthroplasty, hip resurfacing and in small joints.

Anthony Guitterez, Market Manager, Medical Products at Carpenter Technology Corporation, has more than 12 years experience in the specialty metals industry. Current responsibilities include global management and support of Carpenter’s specialty metals for the medical market.

During his career he has served in various business development and technical service roles. Anthony holds a B.S. in Metallurgy from the Colorado School of Mines and an MBA from Boston University. He is an active member of ASM International.

Gregory Juda, PhD is the senior biologics scientist in the Biologics Division at Bacterin International; a manufacturer of donor derived specialty allografts and coated medical devices. He received a Doctorate of Philosophy in Biochemistry from Montana State University-Bozeman. Following a postdoctoral fellowship, Dr. Juda joined the research staff at Bacterin International in August of 2005.

Dr. Juda has guided the development of two revolutionary, life-enhancing products; Bacterin's OsteoSponge™ allograft and a demineralized bone matrix (DBM) putty. He was responsible for directing process validation efforts for Bacterin’s newly opened tissue processing facility including programs for tissue decontamination, facility cleaning validation, and terminal gamma irradiation. Dr. Juda served as principal investigator for a grant awarded by the Montana Board of Research and Commercialization Technology entitled "Demineralized Bone Matrix Putty for Transplantation".

Daniel R. Matlis is the Founder and President of Axendia – a trusted advisor to Life-Science executives on business, technology, and regulatory issues. Dan’s 18-year experience in the life-sciences industry has included projects in research & development, manufacturing, regulatory compliance, business development and information technology.

Prior to founding Axendia, Dan was Vice President and General Manager at Stelex, Inc. – a leading consultancy to life-science companies. He started his professional career at Ethicon, Inc., a Johnson & Johnson Company.

He holds degrees from both Polytechnic University (BS in Electrical Engineering) and New Jersey Institute of Technology (MS in Management). Dan is the chief contributor and editor of Life-Science Panorama – a publication covering business, regulatory and technology issues facing industry executives.

Mr. Rose advises Advisory Board members on marketplace and clinical trends across several specialty areas, with a special focus on the orthopedic service line. He presents routinely at national conferences and serves as a special technology advisor to over 500 health care providers. Mr. Rose was a founding member of the Technology Insights research group, helping to design the program's offerings and establish its ethic of research quality and client service.

Drawing on nearly three decades of experience, The Advisory Board Company serves a membership of more than 2,600 leading hospitals, health systems, universities and other mission-driven enterprises in the United States and, increasingly, worldwide.

Dr. Steven Scott is Chairman of the Scientific Advisory Board and a member of the American Academy of Orthopaedic Surgeons, the Musculoskeletal Tumor Society and the Pediatric Society Orthopaedic of North America. Dr. Scott maintains an active orthopaedic practice in Salt Lake City and has special expertise in the use of Ilizarov external fixation, pediatric orthopaedics, bone graft technology, and orthopedic oncology.

Dr. Scott has authored many scientific publications, has presented at numerous national conferences, and has a patent pending. He received his BA from Linfield College summa cum laude and attended medical school at the University of Colorado. He completed his orthopaedic training at the University of Utah and Mayo Clinic; he holds a clinical appointment within the Department of Orthopaedics at the University of Utah and received an M.B.A. through the University of Utah in 2001.

Anthony G. Viscogliosi is an accomplished founder and developer of orthopedic device technologies and companies. In the 1990s, he became the first Wall Street analyst to focus specifically on the orthopedics industry. He went on to initiate or oversee more than 170 transactions in this dynamic sector.

Mr. Viscogliosi is a founder of Small Bone Innovations, Inc. (SBi) and, in 2005, raised $42.2 million for the company – the single largest round of venture capital financing in orthopedic devices at that time.

Mr. Viscogliosi co-founded, in 1999, Viscogliosi Bros., LLC. He also co-founded a Paradigm Spine, LLC; Spine Solutions, Inc., the ‘ProDisc’ company; Raymedica, Inc., the nucleus arthroplasty developer; and, single use disposable device company, Ascent Healthcare Solutions, Inc. In addition, with his brothers Marc and John, he is a founder of the NYU-HJD Viscogliosi Bros. Spine Center.

Mr. Viscogliosi received his B.S. in Economics from the University of Michigan in 1984. He also received an honorary doctorate degree in 2007 from the New York College of Podiatric Medicine.

Laura is currently Senior Vice President, Global Research and Innovation for Smith & Nephew’s Orthopaedic Reconstruction Division. She has been with Smith & Nephew since 1987, serving in various roles in Research and Development.

Laura has a Master of Science degree in Mechanical Engineering from the University of Memphis and has completed Executive Education courses in business at Northwestern University’s Kellogg Graduate School of Management and at Stanford University. She is a member of several advisory boards, including the University of Memphis College of Engineering Advisory Council and the FedEx Institute of Technology Advisory Board.